文献速递腹部甲状腺与浅表儿科影像CTUS

幼儿单次静脉注射碘对比剂后原发性甲状腺功能障碍:一项倾向评分匹配分析。

Primary thyroid dysfunction after single intravenous iodinated contrast exposure in young children: a propensity score matched analysis.
PubMed 文献 · Pediatr Radiol · 2020-11-17

背景:数据提示儿童使用碘基对比剂(IBCM)后甲状腺功能障碍风险增加。目的:评估幼儿在接受计算机断层扫描(CT)期间单次静脉注射IBCM后促甲状腺激素(TSH)异常的患病率。…

要点

  • 幼儿单次静脉碘对比剂暴露后90天内TSH异常发生率14%(8/57),未暴露组7%(4/57),两组无显著差异。
  • 多因素分析中静脉碘对比剂暴露OR=2.61(95%CI 0.65-10.55,P=0.18),未达统计学显著。
  • 身高(OR=1.25,P=0.0095)与21三体(OR=4.04,P=0.019)是影像后甲状腺功能障碍的独立预测因素。
英文原文(摘要)· 点击展开

BACKGROUND: Data suggest an increased risk of thyroid dysfunction following iodine-based contrast material (IBCM) in children.

OBJECTIVE: To estimate the prevalence of thyroid stimulating hormone (TSH) abnormalities following exposure to a single dose of intravenous IBCM during computed tomography (CT) in young children.

MATERIALS AND METHODS: Inpatients ≤24 months of age who underwent a single CT with intravenous IBCM (exposed cohort) or abdominal ultrasound (US) (unexposed cohort) examination and had a TSH value obtained within 90 days after imaging between January 2009 to November 2018 were identified. Propensity score matching with 20 variables was performed. Primary thyroid dysfunction was defined by abnormally high or low TSH value. Multivariable logistic regression identified risk factors, including intravenous IBCM, for thyroid dysfunction.

RESULTS: From the eligible 4,215 imaging examinations, 114 unique patients were included in the propensity matched population (n=57 per group). Thyroid dysfunction was identified in 14% (8/57) and 7% (4/57) of the IBCM-exposed and IBCM-unexposed cohorts, respectively. No patient in either cohort was started on thyroid hormone supplementation within the 3 months after imaging. Intravenous IBCM exposure was not a significant predictor of thyroid dysfunction on univariable (odds ratio [OR]=2.16, 95% confidence interval [CI]=0.61-7.64, P=0.23) or multivariable (OR=2.61, 95% CI=0.65-10.55, P=0.18) analyses. Significant independent predictors of post-imaging thyroid dysfunction included height (OR=1.25, P=0.0095) and trisomy 21 (OR=4.04, P=0.019).

CONCLUSION: Hospitalized children ≤24 months of age who received a single dose of intravenous IBCM for CT examination had a similar prevalence of TSH abnormalities compared to a propensity score matched group who underwent abdominal US. One dose of intravenous IBCM likely does not cause prolonged TSH abnormalities; however, larger studies are needed.

来源:Pediatr Radiol,查看原文。版权归原作者所有。

引用

  1. Gilligan LA, Dillman JR, Su W, et al. Primary thyroid dysfunction after single intravenous iodinated contrast exposure in young children: a propensity score matched analysis. Pediatr Radiol. 2020. PMID: 33201320. doi:10.1007/s00247-020-04881-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。